These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 7539755

  • 21. Expression of cell interaction molecules by immature rat thymocytes during passage through the CD4+8+ compartment: developmental regulation and induction by T cell receptor engagement of CD2, CD5, CD28, CD11a, CD44 and CD53.
    Mitnacht R, Tacke M, Hünig T.
    Eur J Immunol; 1995 Feb; 25(2):328-32. PubMed ID: 7533082
    [Abstract] [Full Text] [Related]

  • 22. Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes.
    Damle NK, Klussman K, Linsley PS, Aruffo A.
    J Immunol; 1992 Apr 01; 148(7):1985-92. PubMed ID: 1372018
    [Abstract] [Full Text] [Related]

  • 23. T cell receptor aggregation, but not dimerization, induces increased cytosolic calcium concentrations and reveals a lack of stable association between CD4 and the T cell receptor.
    Ratcliffe MJ, Coggeshall KM, Newell MK, Julius MH.
    J Immunol; 1992 Mar 15; 148(6):1643-51. PubMed ID: 1531842
    [Abstract] [Full Text] [Related]

  • 24. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M, Guy R, Waldmann H, Glennie M, Alexander DR.
    Cell Immunol; 1998 May 01; 185(2):101-13. PubMed ID: 9636688
    [Abstract] [Full Text] [Related]

  • 25. HIV-1 gp120/V3-derived epitopes promote activation-induced cell death to superantigen-stimulated CD4+/CD45RO+ T cells.
    Porichis F, Vlata Z, Hatzidakis G, Spandidos DA, Krambovitis E.
    Immunol Lett; 2007 Jan 15; 108(1):97-102. PubMed ID: 17141881
    [Abstract] [Full Text] [Related]

  • 26. Activation with superantigens induces programmed death in antigen-primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism.
    Damle NK, Leytze G, Klussman K, Ledbetter JA.
    Eur J Immunol; 1993 Jul 15; 23(7):1513-22. PubMed ID: 8100773
    [Abstract] [Full Text] [Related]

  • 27. HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens.
    Mann DL, Read-Connole E, Arthur LO, Robey WG, Wernet P, Schneider EM, Blattner WA, Popovic M.
    J Immunol; 1988 Aug 15; 141(4):1131-6. PubMed ID: 2840463
    [Abstract] [Full Text] [Related]

  • 28. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2.
    Lin J, Yon RW, Chavin KD, Qin L, Woodward J, Ding Y, Yagita H, Bromberg JS.
    Transplantation; 1995 Apr 27; 59(8):1162-71. PubMed ID: 7537394
    [Abstract] [Full Text] [Related]

  • 29. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation.
    Hirokawa M, Gray JD, Takahashi T, Horwitz DA.
    J Immunol; 1992 Sep 15; 149(6):1859-66. PubMed ID: 1355500
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. HIV-1 down-regulates CD4 costimulation of TCR/CD3-directed tyrosine phosphorylation through CD4/p56lck dissociation.
    Kanner SB, Haffar OK.
    J Immunol; 1995 Mar 15; 154(6):2996-3005. PubMed ID: 7876562
    [Abstract] [Full Text] [Related]

  • 32. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R, Yssel H, de Vries JE.
    J Immunol; 1993 Jun 01; 150(11):4754-65. PubMed ID: 7684412
    [Abstract] [Full Text] [Related]

  • 33. HIV-gp120 can block CD4-class II MHC-mediated adhesion.
    Rosenstein Y, Burakoff SJ, Herrmann SH.
    J Immunol; 1990 Jan 15; 144(2):526-31. PubMed ID: 1967269
    [Abstract] [Full Text] [Related]

  • 34. Stimulation of human naive and memory T helper cells with bacterial superantigen. Naive CD4+45RA+ T cells require a costimulatory signal mediated through the LFA-1/ICAM-1 pathway.
    Fischer H, Gjörloff A, Hedlund G, Hedman H, Lundgren E, Kalland T, Sjögren HO, Dohlsten M.
    J Immunol; 1992 Apr 01; 148(7):1993-8. PubMed ID: 1347547
    [Abstract] [Full Text] [Related]

  • 35. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7.
    Damle NK, Klussman K, Leytze G, Ochs HD, Aruffo A, Linsley PS, Ledbetter JA.
    Cell Immunol; 1993 Apr 15; 148(1):144-56. PubMed ID: 7684325
    [Abstract] [Full Text] [Related]

  • 36. Markers of lymphocyte homing distinguish CD4 T cell subsets that turn over in response to HIV-1 infection in humans.
    Hengel RL, Jones BM, Kennedy MS, Hubbard MR, McDougal JS.
    J Immunol; 1999 Sep 15; 163(6):3539-48. PubMed ID: 10477629
    [Abstract] [Full Text] [Related]

  • 37. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
    Abe R, Vandenberghe P, Craighead N, Smoot DS, Lee KP, June CH.
    J Immunol; 1995 Feb 01; 154(3):985-97. PubMed ID: 7822814
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Does co-aggregation of the CD45 and CD3 antigens inhibit T cell antigen receptor complex-mediated activation of phospholipase C and protein kinase C?
    Shivnan E, Biffen M, Shiroo M, Pratt E, Glennie M, Alexander D.
    Eur J Immunol; 1992 Apr 01; 22(4):1055-62. PubMed ID: 1532359
    [Abstract] [Full Text] [Related]

  • 40. Association of various T cell-surface molecules with the cytoskeleton. Effect of cross-linking and activation.
    Geppert TD, Lipsky PE.
    J Immunol; 1991 May 15; 146(10):3298-305. PubMed ID: 1673981
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.